Distinct effects of Lactobacillus plantarum KL30B and Escherichia coli 3A1 on the induction and development of acute and chronic inflammation

Central European Journal of Immunology

Volumn 40, Issue 4, 2015, Pages 420-430

  Strus, Magdalena ^a,b   Okoñ, Krzysztof ^a   Nowak, Bernadeta ^a   Pilarczyk Zurek, Magdalena ^a   Heczko, Piotr ^a   Gawda, Anna ^a   Ciszek Lenda, Marta ^a   Skowron, Beata ^a   Baranowska, Agnieszka ^a   Marcinkiewicz, Janusz ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Escherichia coli; Inflammation; Lactobacillus plantarum; Neutrophils; TNBS induced colitis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; MYELOPEROXIDASE; NITRIC OXIDE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CHRONIC INFLAMMATION; CHRONICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; ESCHERICHIA COLI; ESCHERICHIA COLI 3A1; EXPERIMENTAL PERITONITIS; HISTOPATHOLOGY; IN VITRO STUDY; INFLAMMATION; INTESTINE FLORA; LACTOBACILLUS PLANTARUM; LACTOBACILLUS PLANTARUM KL30B; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PERITONEAL CAVITY; PERITONEAL EXUDATE CELL; PERITONEUM MACROPHAGE; RAT; STRAIN DIFFERENCE; TRINITROBENZENE SULFONIC ACID-INDUCED COLITIS;

EID: 84983164496     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: 10.5114/ceji.2015.56963     Document Type: Article

References (44)

1. Sepehri S, Kotlowski R, Bernstein CN, Krause DO (2007): Microbial diversity of inflamed and non-inflamed gut biopsy tissues in inflammatory bowel disease. Inflamm Bowel Dis 13: 675-683.
2. Campieri M, Gionchetti P (2001): Bacteria as the cause of ulcerative colitis. Gut 48: 132-135.
3. Strus M, Uhlig H, Powrie F, et al. (2005): A role of bacteria in inflammatory bowel disease evoked in animal models. Gas-troenterol Pol 12: 15-20.
4. Baumgart M, Dogan B, Rishniw M, et al. (2007): Culture in-dependent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. ISME J 1: 403-418.
5. Nataro JP, Kaper JB (1998): Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
6. Burke DA, Axon ATR (1987): Ulcerative colitis and Esche-richia coli with adhesive properties. J Clin Pathol 40: 782-786.
7. Pilarczyk-Zurek M, Chmielarczyk A, Gosiewski T, et al. (2013): Possible role of Escherichia coli in propagation and perpetuation of chronic inflammation in ulcerative colitis. BMC Gastroenterol 13: 61.
8. Sartor RB. Microbial agents in the pathogenesis, differential diagnosis, and complications of inflammatory bowel disease. In: Blaser MJ, Smith PD, Ravdin JI (eds.). Infections of the gastrointestinal tract. Raven Press, Ltd., New York 2002; 435-458.
9. Rembacken BJ, Snelling AM, Hawkey PM, et al. (1999): Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 354: 635-639.
10. Schultz M, Strauch UG, Linde HJ, et al. (2004): Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis. Clin Diagn Lab Immunol 11: 372-378.
11. Peran L, Camuesco D, Comalada M, et al. (2005): Preventa-tive effects of a probiotic, Lactobacillus salivarius ssp. sali-varius, in the TNBS model of rat colitis. World J Gastroen-terol 11: 5185-5192.
12. Peran L, Sierra S, Comalada M, et al. (2007): A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis. Br J Nutr 97: 96-103.
13. Melgar S, Karlsson A, Michaëlsson E (2005): Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol 288: G1328-G1338.
14. Camuesco D, Peran L, Comalada M, et al. (2005): Preventa-tive effects of lactulose in the trinitrobenzenesulphonic acid model of rat colitis. Inflamm Bowel Dis 11: 265-271.
15. Wengrower D, Zanninelli G, Latella G, et al. (2012): Losar-tan reduces trinitrobenzene sulphonic acid-induced colorectal fibrosis in rats. Can J Gastroenterol 26: 33-39.
16. Yukitake H, Kimura H, Suzuki H, et al. (2011): BTZO-15, and ARE-activator, ameliorates DSS-and TNBS-induced colitis in rats. PLoS One 6: e23256.
17. Marzinzig M, Nussler AK, Stadler J, et al. (1997): Improved methods to measure end products of nitric oxide in biological fluids: nitrite, nitrate, and S-nitrosothiols. Nitric Oxide 1: 177-189.
18. Bradley RP, Christensen RD, Rothstein G (1982): Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60: 618-622.
19. Marcinkiewicz J, Ciszek M, Bobek M, et al. (2007): Differ-ential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int J Exp Pathol 88: 155-164.
20. Larson SJ, Collins SM, Weingarten HP (1996): Dissociation of temperature changes and anorexia after experimental colitis and LPS administration in rats. Am J Physiol 271: R967-972.
21. Peña JA, Li SY, Wilson PH, et al. (2004): Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis. Appl Environ Microbiol 70: 558-568.
22. Knapp S, de Vos AF, Florquin S, et al. (2003): Lipopolysac-charide binding protein is an essential component of the innate immune response to Escherichia coli peritonitis in mice. Infect Immun 71: 6747-6753.
23. Sewnath ME, Olszyna DP, Birjmohun R, et al. (2001): IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol 166: 6323-6331.
24. Nakanishi Y, Sato T, Ohteki T (2015): Commensal Gram-pos-itive bacteria initiates colitis by inducing monocyte/macro-phage mobilization. Mucosal Immunol 8: 152-160.
25. McCafferty DM, Miampamba M, Sihota E, et al. (1999): Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 45: 864-873.
26. Cross RK, Wilson KT (2003): Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 9: 179-189.
27. Li B, Alli R, Vogel P, Geiger TL (2014): IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis. Mucosal Immunol 7: 869-878.
28. Zhu MY, Lu YM, Ou YX, et al. (2012): Dynamic progress of 2, 4, 6-trinitrobenzene sulfonic acid induced chronic colitis and fibrosis in rat model. J Dig Dis 13: 421-429.
29. Rath HC, Schultz M, Freitag R, et al. (2001): Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 69: 2277-2285.
30. Satish Kumar CS, Kondal Reddy K, Reddy AG, et al. (2015): Protective effect of Lactobacillus plantarum 21, a probiotic on trinitrobenzenesulfonic acid-induced ulcerative colitis in rats. Int Immunopharmacol 25: 504-510.
31. Sartor RB (1997): Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92: 5S-11S.
32. Naito Y, Takagi T, Yoshikawa T (2007): Neutrophil-depen-dent oxidative stress in ulcerative colitis. J Clin Biochem Nutr 41: 18-26.
33. Yasukawa K, Tokuda H, Tun X, et al. (2012): The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis. Free Radic Res 46: 1427-1436.
34. Rumi G, Tsubouchi R, Nishio H, et al. (2004): Dual role of endogenous nitric oxide in development of dextran sodium sulfate-induced colitis in rats. J Physiol Pharmacol 55: 823-836.
35. Tun X, Yasukawa K, Yamada K (2014): Involvement of nitric oxide with activation of Toll-like receptor 4 signaling in mice with dextran sodium sulfate-induced colitis. Free Radic Biol Med 74: 108-117.
36. Buell MG, Berin MC (1994): Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat. Dig Dis Sci 39: 2575-2588.
37. Campbell EL, Bruyninckx WJ, Kelly CJ, et al. (2014): Trans-migrating neutrophils shape the mucosal microenvironment through localized oxygen depletion to influence resolution of inflammation. Immunity 40: 66-77.
38. Fridlender ZG, Albelda SM (2012): Tumor-associated neutro-phils: friend or foe? Carcinogenesis 33: 949-955.
39. Piccard H, Muschel RJ, Opdenakker G (2012): On the dual roles and polarized phenotypes of neutrophils in tumor development and progression. Crit Rev Oncol Hematol 82: 296-309.
40. Jang SE, Han MJ, Kim SY, Kim DH (2014): Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. Int Immunopharmacol 21: 186-192.
41. Mileti E, Matteoli G, Iliev ID, Rescigno M (2009): Comparison of the immunomodulatory properties of three probiotic strains of Lactobacilli using complex culture systems: predic-tion for in vivo efficacy. PLoS One 4: e7056.
42. Klebanoff SJ (2005): Myeloperoxidase: friend and foe. J Leu-koc Biol 77: 598-625.
43. Prokopowicz Z, Marcinkiewicz J, Katz DR, Chain BM (2012): Neutrophil myeloperoxidase: soldier and statesman. Arch Immunol Ther Exp 60: 43-54.
44. Kumar AP, Ryan C, Cordy V, Reynolds WF (2005): Induc-ible nitric oxide synthase expression is inhibited by myelop-eroxidase. Nitric Oxide 13: 42-53.